Follow
Gillian Dekkers
Gillian Dekkers
Scientist, QVQ B.V.
Verified email at qvquality.com
Title
Cited by
Cited by
Year
IgG subclasses and allotypes: from structure to effector functions
G Vidarsson, G Dekkers, T Rispens
Frontiers in immunology 5, 117227, 2014
28812014
Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor-and complement-mediated-effector activities
G Dekkers, L Treffers, R Plomp, AEH Bentlage, M de Boer, ...
Frontiers in immunology 8, 279269, 2017
3262017
Affinity of human IgG subclasses to mouse Fc gamma receptors
G Dekkers, AEH Bentlage, TC Stegmann, HL Howie, ...
MAbs 9 (5), 767-773, 2017
2062017
Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans
G Dekkers, R Plomp, CAM Koeleman, R Visser, HH Von Horsten, ...
Scientific reports 6 (1), 36964, 2016
1412016
Hinge-region O-glycosylation of human immunoglobulin G3 (IgG3)*[S]
R Plomp, G Dekkers, Y Rombouts, R Visser, CAM Koeleman, ...
Molecular & cellular proteomics 14 (5), 1373-1384, 2015
1222015
Glycosylation pattern of anti‐platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia
ME Sonneveld, S Natunen, S Sainio, CAM Koeleman, S Holst, G Dekkers, ...
British journal of haematology 174 (2), 310-320, 2016
1122016
Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages
SQ Nagelkerke, G Dekkers, I Kustiawan, FS van de Bovenkamp, ...
Blood, The Journal of the American Society of Hematology 124 (25), 3709-3718, 2014
1092014
Novel Concepts of altered immunoglobulin G Galactosylation in autoimmune diseases
G Dekkers, T Rispens, G Vidarsson
Frontiers in immunology 9, 553, 2018
952018
Identification of sequence variants influencing immunoglobulin levels
S Jonsson, G Sveinbjornsson, AL de Lapuente Portilla, B Swaminathan, ...
Nature genetics 49 (8), 1182-1191, 2017
932017
Enhanced effector functions due to antibody defucosylation depend on the effector cell Fcγ receptor profile
CW Bruggeman, G Dekkers, AEH Bentlage, LW Treffers, SQ Nagelkerke, ...
The Journal of Immunology 199 (1), 204-211, 2017
782017
Functional attributes of antibodies, effector cells, and target cells affecting NK cell–mediated antibody-dependent cellular cytotoxicity
AR Temming, SW de Taeye, EL de Graaf, LA de Neef, G Dekkers, ...
The Journal of Immunology 203 (12), 3126-3135, 2019
752019
Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1
LE McCoy, L Rutten, D Frampton, I Anderson, L Granger, ...
PLoS pathogens 10 (12), e1004552, 2014
532014
Human DC-SIGN and CD23 do not interact with human IgG
AR Temming, G Dekkers, FS van de Bovenkamp, HR Plomp, ...
Scientific reports 9 (1), 9995, 2019
522019
Conserved FcγR-glycan discriminates between fucosylated and afucosylated IgG in humans and mice
G Dekkers, AEH Bentlage, R Plomp, R Visser, CAM Koeleman, ...
Molecular immunology 94, 54-60, 2018
372018
Glycoengineering HIV-1 Env creates ‘supercharged’and ‘hybrid’glycans to increase neutralizing antibody potency, breadth and saturation
ET Crooks, SL Grimley, M Cully, K Osawa, G Dekkers, K Saunders, ...
PLoS pathogens 14 (5), e1007024, 2018
272018
IgG subclass determines suppression versus enhancement of humoral alloimmunity to kell RBC antigens in mice
P Shinde, HL Howie, TC Stegmann, AEH Bentlage, ...
Frontiers in immunology 11, 555984, 2020
162020
Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation
WJJ Falkenburg, AC Kempers, G Dekkers, P Ooijevaar-de Heer, ...
Rheumatology 56 (11), 2025-2030, 2017
152017
IgG glyco-engineering to improve IVIg potency
CW Bruggeman, G Dekkers, R Visser, NWM Goes, TK Van den Berg, ...
Frontiers in immunology 9, 393667, 2018
112018
Anti-HIV-1 Nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate fc effector functions
AI Schriek, MM van Haaren, G Dekkers, AEH Bentlage, G Vidarsson, ...
Frontiers in immunology 13, 893648, 2022
102022
Biophysical evaluation of rhesus macaque Fc gamma receptors reveals similar IgG Fc glycoform preferences to human receptors
AR Crowley, NY Osei-Owusu, G Dekkers, W Gao, M Wuhrer, DM Magnani, ...
Frontiers in Immunology 12, 754710, 2021
92021
The system can't perform the operation now. Try again later.
Articles 1–20